Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx xxxxxxx, že xxx 16. listopadu 2007 bylo generálním xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x metod xxxxxxx.

Xxxxxxx X vstoupila x platnost x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 x tímto xxxx vstoupila x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Xxxx xxxxxx Xxxxxxx I x platnost xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Přílohy X a xxxx xxxxxxx xx xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx látky xxxx xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazol); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); methyl-1-testosteron (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-homo-pregna-4,9,11-trien-17β-ol-3-on); xxxxxxxxx x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, prasteron (xxxxxxxxxxxxxxxxxxxxx, XXXX), testosteron x xxxxxxxxxxx xxxxxxxxxx x isomery:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxx přirozeně, xxxx se xxx xx xx, xx Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx a xxxx hlášen xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx jakýkoli xxxx xxxxxxxxx poměr ve Xxxxxx Sportovce xxxxxxxx xxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx u xxxx xxx, xx xxxxxxxxxx normální endogenní xxxxxxxx. Xxxxxx xx xxx xx to, xx Xxxxxx xxxxxxxx Xxxxxxxxx látku x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx prokáže, xx xx koncentrace Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Sportovce xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx stavem.

Xxxx xx xxx xx xx, xx Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx ve všech xxxxxxxxx x při xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Xxxxxxxx látka xxxxxxxxxx původu. X xxxxxxx případě xxxx xxxxx xxxxxxxx další xxxxxxx.

Když xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx hodnot, xxxxx xx normálně vyskytují x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, ale xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, jako xxxx. xxxxxxxxx s xxxxxxxxxxx xxxxxxxxxxxx steroidními xxxxxxx, nebo když xxxxxxxxx xxxxxxxxx poměr X/X xxxxx xxx xxxxx (4) xx xxxxx (1) x xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní původ xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx organizace xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx vyžadováno takové xxxxx xxxxxxx, pak xxxxxxxx xxxx xxxxxxxxxx xxxxxx jako neobvyklý x ne jako xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx xxxxx xxxxxxxx xxxxx šetření, x xxxx xx xxx xx to, xx Xxxxxx xxxxxxxx Zakázanou xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, bude xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx xxx, xx xxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx x následujících 3 měsících třikrát xxxxxxxx xxx předchozího xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx tuto xxxxxxxxxxxxxx xxxxxx, bude xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx následnými xxxxx, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx vzácných individuálních xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx boldenon endogenního xxxxxx xx velice xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila a xxxxxxx xxxxxxxxxx analytické xxxxxx (např. XXXX) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, může xxx provedeno další xxxxxxx provedením následného xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx za xxxxxxx a xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

V xxxxxxx, xx Xxxxxxxxx nebude xxxxxxxxxxxxx při xxxxxxx xxxxxxxxx, xxxx xx xxx za xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, xxxxxxxxxx, ale xx s xxxxxxxx xxxxx xx xx.

X2. XXXXXXX A PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx hormon (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx růstové xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), xxxxxxxx xxx x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx či xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx či xxxxxxxxxx x/xxxx příslušné xxxxxx xx Xxxxxx Sportovce xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxx x xxxx tak, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Pokud xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx exogenního xxxxxx, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx X- a X-xxxxxxx xxxx zakázáni.

Xxxxxxxx xxxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, xxx které xx xxx inhalaci xxxxx udělení xxxxxxxx xxxxxxxxxxxx xxxxxxx.

X xxxx byla xxxxxxx xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, xxxx nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) vyšší xxx 1000 xxxxxxxxx v 1 mililitru xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx byl xxxxxxxx terapeutickým užíváním xxxxxxxxxxx v xxxxxxxx.

X4. ANTAGONISTÉ X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx ne x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX XXXXX

Maskovací xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, epitestosteron, probenecid, xxxxxxxxxx alfa-reduktázy (např. xxxxxxxxxx, xxxxxxxxxx), plasmaexpandery (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) x další xxxxx x xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (např. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx xxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x prahovou xxxx podprahovou xxxxxxxx xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX PŘENOSU XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx buněk, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx exprese xxxx, xxxxx xxxx xxxxxxxxx xxxxxx sportovní výkon, xx xxxxxxxx.

X6. XXXXXXXXXXX

Všechna xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx optických (X- a X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx x případě xxxxxx xxxxxxxx užití x stimulancií xxxxxxxxxx xx Xxxxxxxxxxxxxx programu xxx xxx 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, ethylamfetamin, famprofazon, xxxxxxxxxxx, fendimetrazin, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, fenkamin, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (karfedon), xxxxxxxxxx, heptaminol, isomethepten, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, norfenfluramin, oktopamin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, pentetrazol, p-methylamfetamin, xxxxxxxxx, propylhexedrin, selegilin, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxxxxx xxxxxxxxx výslovně xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx za xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx xxxxxxxxxx x běžných xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx antidopingových xxxxxxxx, xxxx xx u xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx jako xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx narkotika xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční aplikace (xxxxxxxxxxxx, do okolí xxxxxx, xx xxxxx xxxxxx, epidurální, xx xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx níže xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx kožní (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx zakázané x nevyžadují žádnou xxxxx terapeutické výjimky.

X1. XXXXXXX

Alkohol (etanol) xx xxxxxxxx xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx zkouškou a/nebo xxxxxxxx xxxx. Prahová xxxxxxx pro xxxxxxxx xxxxxxxxxxx pravidla (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxxx (WKF) (0.10 x/x)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) jen xxx xxxxxxxxxx xx střelbou (0.10 x/x)

∙ Motocyklový xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 g/l)

∙ Xxxxxxx (IPC) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx jinak xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při xxxxxxx x následujících sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx a xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Lyžování (XXX) - xxxxx na xxxxxx a xxxxxxxxxxx xxxxxxxx-xxxxx a U-rampa, x snowboard X-xxxxx x "big xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - jen xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx sporty (XXXX, IPC "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (zakázané xxxx Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (UIM)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, bisoprolol, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx xxxxx na xx

"Xxxxxxxxxx látky"* xxxx vyjmenovány níže:

∙ Xxxxxxx Beta-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (xxxxxxx xxxx xxxxxxxxxxx) při xxxxxxxx xxxxxx xxx 1000 xx/xx xxxx x clenbuterolu (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, famprofazon, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx stimulancia neuvedená xxxxxxxx v xxxxxx X6, xxx která Xxxxxxxxx prokáže, xx xxxxxxx podmínky xxxxxxx x xxxxxx X6;

∙ Kanabinoidy;

∙ Xxxxxxx Glukokortikosteroidy;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x nichž je xxxxx xxxxxxxxxxxxxxx, xx xxxxx úspěšně xxxxxxxx xxxx xxxxxxxxx činidla." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Sportovec xxxx xxxxx prokázat, xx Xxxxxxx xxxxxxxxxx látky xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx shora uvedeného xxxxxxxx xxxxxxxx.